Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea.
Kang DY, Yun J, Lee SY, Koh YI, Sim DW, Kim S, Nam YH, Park JW, Kim SH, Ye YM, Park HK, Kim MH, Jee YK, Jung JW, Yang MS, Kim SH, Lee JK, Kim CW, Hur GY, Kim MY, Park SJ, Kwon YE, Choi JH, Kim JH, Kim SH, La HO, Kang MG, Park CS, Lee SM, Jeong YY, Kim HK, Jin HJ, Jeong JW, Lee J, Lee YW, Lee SE, Kim MS, Kang HR; Korean Severe Cutaneous Adverse Reactions Consortium. Kang DY, et al. Among authors: nam yh. J Allergy Clin Immunol Pract. 2021 Feb;9(2):929-936.e7. doi: 10.1016/j.jaip.2020.09.011. Epub 2020 Sep 19. J Allergy Clin Immunol Pract. 2021. PMID: 32961314
Unique Clinical Characteristics and Prognosis of Allopurinol-Induced Severe Cutaneous Adverse Reactions.
Park HJ, Yun J, Kang DY, Park JW, Koh YI, Kim S, Kim SH, Nam YH, Jeong YY, Kim CW, Park HK, Kim SH, Kang HR, Jung JW; Drug Allergy Work Group of KAAACI. Park HJ, et al. Among authors: nam yh. J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2739-2749.e3. doi: 10.1016/j.jaip.2019.05.047. Epub 2019 Jun 13. J Allergy Clin Immunol Pract. 2019. PMID: 31201937
Acute urticaria induced by oral methylprednisolone.
Jang EJ, Jin HJ, Nam YH, Kim JH, Ye YM, Park HS. Jang EJ, et al. Among authors: nam yh. Allergy Asthma Immunol Res. 2011 Oct;3(4):277-9. doi: 10.4168/aair.2011.3.4.277. Epub 2011 Jul 26. Allergy Asthma Immunol Res. 2011. PMID: 21966609 Free PMC article.
Role of TSLP in Nasal Polyp Inflammation.
Kim JH, Jin HJ, Nam YH, Park HS. Kim JH, et al. Among authors: nam yh. Allergy Asthma Immunol Res. 2011 Jul;3(3):146-7. doi: 10.4168/aair.2011.3.3.146. Epub 2011 May 20. Allergy Asthma Immunol Res. 2011. PMID: 21738879 Free PMC article. No abstract available.
A Randomized, Noninferiority Trial Comparing ICS + LABA with ICS + LABA + LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study.
Park SY, Kim S, Kim JH, Kim SH, Lee T, Yoon SY, Kim MH, Moon JY, Yang MS, Jung JW, Kim JH, Choi JH, Park CS, Kim S, Lee J, Kwon JW, Hur GY, Kim SH, Kim HK, Shin YS, Kim SH, Nam YH, Jang AS, Park SY, Kim TB; Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) Study Group. Park SY, et al. Among authors: nam yh. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1304-1311.e2. doi: 10.1016/j.jaip.2020.09.066. Epub 2020 Nov 9. J Allergy Clin Immunol Pract. 2021. PMID: 33184024 Clinical Trial.
Multicenter Prospective Observational Study to Evaluate the Therapeutic Effect and Safety of a Combination of Montelukast and Levocetirizine for Allergic Rhinitis when Administered to Patients with Allergic Rhinitis and Asthma.
Kim MH, Sohn KH, Park HJ, Nam YH, Kim MH, Jung JW, Kwon JW, Shin YS, Park JS, Cho YJ, Park CS, Choi BW. Kim MH, et al. Among authors: nam yh. Int Arch Allergy Immunol. 2022;183(12):1251-1258. doi: 10.1159/000526094. Epub 2022 Oct 7. Int Arch Allergy Immunol. 2022. PMID: 36209731
192 results